Table 6 Analysis for factors influence the TMTA and TMTB scores of T2DM patients with NAFLD.
| Â | TMTA | TMTB | ||||||
|---|---|---|---|---|---|---|---|---|
|  | P | β | 95% CI for β | P | β | 95% CI for β | ||
Age | 0.293 | 0.375 | -0.317 | 1.302 | 0.756 | -0.373 | -2.762 | 2.016 |
Gender | 0.678 | 1.989 | 7.547 | 11.526 | 0.628 | -8.216 | -41.989 | 25.558 |
Duration of DM | 0.463 | -0.262 | -0.972 | 0.488 | 0.337 | -1.217 | -3.732 | 1.298 |
Duration of HBP | 0.399 | -0.273 | -0.917 | 0.371 | 0.682 | -0.469 | -2.750 | 1.811 |
HbA1c | 0.911 | 0.143 | -2.408 | 2.695 | 0.768 | -1.340 | -10.375 | 7.696 |
BMI | 0.486 | 0.639 | -1.187 | 2.464 | 0.308 | 3.320 | -3.145 | 9.786 |
TG | 0.956 | -0.078 | -2.927 | 2.771 | 0.193 | -6.636 | -16.726 | 3.455 |
HDL | 0.158 | -12.485 | -29.959 | 4.989 | 0.894 | -4.127 | -66.011 | 57.757 |
HOMA-IR | 0.032* | 5.911 | 0.532 | 11.450 | 0.007** | 27.077 | 7.742 | 46.411 |